Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects. 1981

G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba

A compartmental model formed by plasma glucose, proinsulin, insulin, and C-peptide was proposed to allow a quantitative evaluation of the interrelationship among the different components of the system and to obtain a better discrimination between normal and pathologic subjects. In 11 control subjects, in 6 mild diabetics, and in 9 severe diabetics (insulin-dependent), the kinetics of plasma glucose, insulin, and C-peptide after an i.v. injection of glucagon (sampling for about 120 min) were fitted to the model which was solved with digital computing techniques. Since biphasic plasma insulin and C-peptide kinetics were demonstrated in many normals and mild diabetics, the effect of glucagon in the model was represented by a differential plus a proportional effect. The model (formed by 6 compartments and 14 transfer constants) takes into account the fact that insulin and C-peptide derive monomolecularly from proinsulin and that liver inactivates insulin. The values of the parameters obtained were submitted to stepwise discriminant analysis in order to obtain their relative importance in discriminating among the three groups of subjects. With respect to normal subjects, we found in diabetics an increased inflow of glucose into plasma; a decreased effect of glucagon in promoting the proinsulin response; a decreased effect of glucose in promoting the proinsulin response; a decreased glucose utilization; a lower coupling effect of insulin on glucose; and a higher disappearance rate of C-peptide. We observed a lower formation of insulin and C-peptide from proinsulin in severe diabetics.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Related Publications

G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
January 1988, Acta endocrinologica,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
February 1977, The Tohoku journal of experimental medicine,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
January 1980, Journal of endocrinological investigation,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
January 1981, Acta diabetologica latina,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
January 1983, Panminerva medica,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
May 1969, Diabetes,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
November 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
October 1974, The Tohoku journal of experimental medicine,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
February 1982, The Tohoku journal of experimental medicine,
G Turco, and C Brossa, and M D'Alberto, and G Regis, and G Segre, and E Bianchi, and B Bruni, and S Gamba
January 1981, Acta diabetologica latina,
Copied contents to your clipboard!